{"title":"弥合数字健康的实施差距:公平医疗创新的转化研究势在必行","authors":"Laiba Husain, Katherine Kitchens, Saroop Raja, Madiha Memon","doi":"10.1111/cts.70375","DOIUrl":null,"url":null,"abstract":"<p>Digital health technologies' potential to democratize healthcare access appears constrained by implementation challenges that may reproduce existing inequities. This paper examines systemic barriers potentially impeding translation, suggesting prevailing frameworks inadequately address structural determinants. Despite substantial investment, limited FDA approvals for digital-derived endpoints indicate possible regulatory-innovation disjunctures, while constrained funding and incomplete reimbursement structures systematically exclude essential services. We propose a precision implementation framework repositioning implementation science as integral to technological development, potentially challenging linear translational paradigms. This approach emphasizes examining sociotechnical systems, organizational readiness variations, and community-specific contexts. Whether digital health mitigates or exacerbates disparities likely depends on reconceptualizing implementation as socio-organizational transformation requiring regulatory harmonization, sustainable economic models, and equity-centered engagement.</p>","PeriodicalId":50610,"journal":{"name":"Cts-Clinical and Translational Science","volume":"18 10","pages":""},"PeriodicalIF":2.8000,"publicationDate":"2025-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ascpt.onlinelibrary.wiley.com/doi/epdf/10.1111/cts.70375","citationCount":"0","resultStr":"{\"title\":\"Bridging Implementation Gaps in Digital Health: A Translational Research Imperative for Equitable Healthcare Innovation\",\"authors\":\"Laiba Husain, Katherine Kitchens, Saroop Raja, Madiha Memon\",\"doi\":\"10.1111/cts.70375\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Digital health technologies' potential to democratize healthcare access appears constrained by implementation challenges that may reproduce existing inequities. This paper examines systemic barriers potentially impeding translation, suggesting prevailing frameworks inadequately address structural determinants. Despite substantial investment, limited FDA approvals for digital-derived endpoints indicate possible regulatory-innovation disjunctures, while constrained funding and incomplete reimbursement structures systematically exclude essential services. We propose a precision implementation framework repositioning implementation science as integral to technological development, potentially challenging linear translational paradigms. This approach emphasizes examining sociotechnical systems, organizational readiness variations, and community-specific contexts. Whether digital health mitigates or exacerbates disparities likely depends on reconceptualizing implementation as socio-organizational transformation requiring regulatory harmonization, sustainable economic models, and equity-centered engagement.</p>\",\"PeriodicalId\":50610,\"journal\":{\"name\":\"Cts-Clinical and Translational Science\",\"volume\":\"18 10\",\"pages\":\"\"},\"PeriodicalIF\":2.8000,\"publicationDate\":\"2025-10-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ascpt.onlinelibrary.wiley.com/doi/epdf/10.1111/cts.70375\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cts-Clinical and Translational Science\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://ascpt.onlinelibrary.wiley.com/doi/10.1111/cts.70375\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cts-Clinical and Translational Science","FirstCategoryId":"3","ListUrlMain":"https://ascpt.onlinelibrary.wiley.com/doi/10.1111/cts.70375","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
Bridging Implementation Gaps in Digital Health: A Translational Research Imperative for Equitable Healthcare Innovation
Digital health technologies' potential to democratize healthcare access appears constrained by implementation challenges that may reproduce existing inequities. This paper examines systemic barriers potentially impeding translation, suggesting prevailing frameworks inadequately address structural determinants. Despite substantial investment, limited FDA approvals for digital-derived endpoints indicate possible regulatory-innovation disjunctures, while constrained funding and incomplete reimbursement structures systematically exclude essential services. We propose a precision implementation framework repositioning implementation science as integral to technological development, potentially challenging linear translational paradigms. This approach emphasizes examining sociotechnical systems, organizational readiness variations, and community-specific contexts. Whether digital health mitigates or exacerbates disparities likely depends on reconceptualizing implementation as socio-organizational transformation requiring regulatory harmonization, sustainable economic models, and equity-centered engagement.
期刊介绍:
Clinical and Translational Science (CTS), an official journal of the American Society for Clinical Pharmacology and Therapeutics, highlights original translational medicine research that helps bridge laboratory discoveries with the diagnosis and treatment of human disease. Translational medicine is a multi-faceted discipline with a focus on translational therapeutics. In a broad sense, translational medicine bridges across the discovery, development, regulation, and utilization spectrum. Research may appear as Full Articles, Brief Reports, Commentaries, Phase Forwards (clinical trials), Reviews, or Tutorials. CTS also includes invited didactic content that covers the connections between clinical pharmacology and translational medicine. Best-in-class methodologies and best practices are also welcomed as Tutorials. These additional features provide context for research articles and facilitate understanding for a wide array of individuals interested in clinical and translational science. CTS welcomes high quality, scientifically sound, original manuscripts focused on clinical pharmacology and translational science, including animal, in vitro, in silico, and clinical studies supporting the breadth of drug discovery, development, regulation and clinical use of both traditional drugs and innovative modalities.